Intracellular Viral Processing, Not Single-Stranded DNA Accumulation, Is Crucial for Recombinant Adeno-Associated Virus Transduction
Open Access
- 15 December 2004
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 78 (24) , 13678-13686
- https://doi.org/10.1128/jvi.78.24.13678-13686.2004
Abstract
Adeno-associated virus (AAV) is a unique gene transfer vector which takes approximately 4 to 6 weeks to reach its expression plateau. The mechanism for this slow-rise expression profile was proposed to be inefficient second-strand DNA synthesis from the input single-stranded (ss) DNA viral genome. In order to clarify the status of ss AAV genomes, we generated AAV vectors labeled with bromodeoxyuridine (BrdU), a nucleotide analog that can be incorporated into the AAV genome and packaged into infectious virions. Since BrdU-DNA can be detected only by an anti-BrdU antibody when DNA is in an ss form, not in a double-stranded (ds) form, ss AAV genomes with BrdU can be readily tracked in situ. Although ss AAV DNA was abundant by Southern blot analysis, free ss AAV genomes were not detectable after AAV transduction by this new detection method. Further Southern blot analysis of viral DNA and virions revealed that ss AAV DNA was protected within virions. Extracted cellular fractions demonstrated that viral particles in host cells remained infectious. In addition, a significant amount of AAV genomes was degraded after AAV transduction. Therefore, we conclude that the amount of free ss DNA is not abundant during AAV transduction. AAV transduction is limited by the steps that affect AAV ss DNA release (i.e., uncoating) before second-strand DNA synthesis can occur. AAV ss DNA released from viral uncoating is either converted into ds DNA efficiently or degraded by cellular DNA repair mechanisms as damaged DNA. This study elucidates a mechanism that can be exploited to develop new strategies to improve AAV vector transduction efficiency.Keywords
This publication has 48 references indexed in Scilit:
- Improved transduction of primary murine hepatocytes by recombinant adeno-associated virus 2 vectors in vivoGene Therapy, 2004
- Rapid Uncoating of Vector Genomes Is the Key toEfficient Liver Transduction with Pseudotyped Adeno-Associated VirusVectorsJournal of Virology, 2004
- Second-Strand Genome Conversion of Adeno-Associated Virus Type 2 (AAV-2) and AAV-5 Is Not Rate Limiting following Apical Infection of Polarized Human Airway EpitheliaJournal of Virology, 2003
- Infection of Purified Nuclei by Adeno-associated Virus 2Molecular Therapy, 2001
- Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesisGene Therapy, 2001
- Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virusJournal of Clinical Investigation, 2000
- Two Independent Molecular Pathways for Recombinant Adeno-Associated Virus Genome Conversion Occur after UV-C and E4orf6 Augmentation of TransductionHuman Gene Therapy, 1999
- Site-specific integration by adeno-associated virus: a basis for a potential gene therapy vectorGene Therapy, 1997
- Effects of Gamma Irradiation on the Transduction of Dividing and Nondividing Cells in Brain and Muscle of Rats by Adeno-Associated Virus VectorsHuman Gene Therapy, 1996
- Adeno-associated virus: integration at a specific chromosomal locusCurrent Opinion in Genetics & Development, 1993